SCHEMBL2489530

SCHEMBL2489530

Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.85
KIT P10721 10/20 0.85
PDGFRA P16234 9/20 0.85
HDAC1 Q13547 7/20 0.76
HDAC6 Q9UBN7 7/20 0.76
HDAC3 O15379 5/20 0.76
HDAC4 P56524 5/20 0.76
HDAC7 Q8WUI4 5/20 0.76
HDAC2 Q92769 5/20 0.76
HDAC10 Q969S8 5/20 0.76
HDAC11 Q96DB2 5/20 0.76
HDAC8 Q9BY41 5/20 0.76
HDAC9 Q9UKV0 5/20 0.76
HDAC5 Q9UQL6 5/20 0.76
FLT1 P17948 4/20 0.72
FLT4 P35916 3/20 0.72
ABCB11 O95342 2/20 0.72
CYP3A4 P08684 2/20 0.72
CYP2D6 P10635 2/20 0.72
CYP2C9 P11712 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20729866 0.92 KDR (0.81) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL20729853 0.92 KDR (0.83) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL23587680 0.92 KDR (0.71) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL13528237 0.90 KDR (0.78) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL20729841 0.87 HDAC1 (1.00) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL1687028 0.86 ABCB11 (0.73) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL20729840 0.85 KDR (0.73) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL5799466 0.85 KDR (0.74) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL8213998 0.85 KDR (0.74) KDRKITPDGFRAHDAC1HDAC6
SCHEMBL27929736 0.85 KDR (0.74) KDRKITPDGFRAHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380572-A1 Cancer treatment method Glaxosmithkline LLC (US) 2011-10-26 EP disclosed